2025 France Allergy Immunotherapy Revenue Opportunities Report
Description
The 2025 France Allergy Immunotherapy Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Immunotherapy by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in allergy immunotherapy in France are Stallergenes Greer, ALK-Abelló, Allergy Therapeutics, and DBV Technologies. Stallergenes Greer, headquartered in London but very active in France, is a major player, recently launching products like Orylmyte® for house dust mite allergy and iPUMP®, a connected allergy management system used by over 1,300 patients in France. ALK-Abelló, a Danish company, is also significant in the French market, known globally for its allergy immunotherapy products and holding a strong presence in Europe. Allergy Therapeutics, acquired by Stallergenes Greer in 2023, focuses on subcutaneous immunotherapy with promising clinical trial results for grass pollen allergies. Lastly, France-based DBV Technologies specializes in food allergy treatments, notably for peanut allergy, with positive Phase III trial outcomes and a growing footprint in French allergy care.
These companies dominate a French allergy immunotherapy market expected to grow steadily, with a market value projected to reach USD 662 million by 2027 at about 8% CAGR. They contribute through subcutaneous and sublingual immunotherapy, addressing rising allergic conditions like allergic rhinitis and asthma. The French market benefits from innovative therapies, digital adherence tools, and strong R&D pipelines, driving improved patient outcomes in allergy management.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Immunotherapy by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in allergy immunotherapy in France are Stallergenes Greer, ALK-Abelló, Allergy Therapeutics, and DBV Technologies. Stallergenes Greer, headquartered in London but very active in France, is a major player, recently launching products like Orylmyte® for house dust mite allergy and iPUMP®, a connected allergy management system used by over 1,300 patients in France. ALK-Abelló, a Danish company, is also significant in the French market, known globally for its allergy immunotherapy products and holding a strong presence in Europe. Allergy Therapeutics, acquired by Stallergenes Greer in 2023, focuses on subcutaneous immunotherapy with promising clinical trial results for grass pollen allergies. Lastly, France-based DBV Technologies specializes in food allergy treatments, notably for peanut allergy, with positive Phase III trial outcomes and a growing footprint in French allergy care.
These companies dominate a French allergy immunotherapy market expected to grow steadily, with a market value projected to reach USD 662 million by 2027 at about 8% CAGR. They contribute through subcutaneous and sublingual immunotherapy, addressing rising allergic conditions like allergic rhinitis and asthma. The French market benefits from innovative therapies, digital adherence tools, and strong R&D pipelines, driving improved patient outcomes in allergy management.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
